BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 18798279)

  • 1. Heparanase induces VEGF C and facilitates tumor lymphangiogenesis.
    Cohen-Kaplan V; Naroditsky I; Zetser A; Ilan N; Vlodavsky I; Doweck I
    Int J Cancer; 2008 Dec; 123(11):2566-73. PubMed ID: 18798279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.
    Cohen-Kaplan V; Doweck I; Naroditsky I; Vlodavsky I; Ilan N
    Cancer Res; 2008 Dec; 68(24):10077-85. PubMed ID: 19074873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase activity correlates with lymphangiogenesis and vascular endothelial growth factor-C expression in head and neck squamous cell carcinoma.
    Franchi A; Massi D; Santucci M; Masini E; Rossi Degl'Innocenti D; Magnelli L; Fanti E; Naldini A; Ardinghi C; Carraro F; Gallo O
    J Pathol; 2006 Feb; 208(3):439-45. PubMed ID: 16278821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
    Doweck I; Feibish N
    Adv Exp Med Biol; 2020; 1221():847-856. PubMed ID: 32274741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
    Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
    J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
    Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
    Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis.
    Kobayashi S; Kishimoto T; Kamata S; Otsuka M; Miyazaki M; Ishikura H
    Cancer Sci; 2007 May; 98(5):726-33. PubMed ID: 17425689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The close correlation between heparanase and COX-2 expression in lymphangiogenesis of cervical cancer.
    Zeng C; Chen L; Yang Z; Sun S
    Med Oncol; 2014 Dec; 31(12):314. PubMed ID: 25370734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangiogenesis in gastric carcinoma correlates with prognosis.
    Gao P; Zhou GY; Zhang QH; Su ZX; Zhang TG; Xiang L; Wang Y; Zhang SL; Mu K
    J Pathol; 2009 Jun; 218(2):192-200. PubMed ID: 19224540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C/ERK pathway.
    Yu S; Lv H; Zhang H; Jiang Y; Hong Y; Xia R; Zhang Q; Ju W; Jiang L; Ou G; Zhang J; Wang S; Zhang J
    Biochem Biophys Res Commun; 2017 Apr; 485(2):432-439. PubMed ID: 28209511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
    Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
    Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.
    Doweck I; Kaplan-Cohen V; Naroditsky I; Sabo E; Ilan N; Vlodavsky I
    Neoplasia; 2006 Dec; 8(12):1055-61. PubMed ID: 17217623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
    Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
    Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
    Ma C; Luo C; Yin H; Zhang Y; Xiong W; Zhang T; Gao T; Wang X; Che D; Fang Z; Li L; Xie J; Huang M; Zhu L; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Gastric Cancer; 2018 Jul; 21(4):617-631. PubMed ID: 29243194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C.
    Du Q; Jiang L; Wang X; Wang M; She F; Chen Y
    Cancer Sci; 2014 Oct; 105(10):1261-71. PubMed ID: 25154789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase activation induces epidermal hyperplasia, angiogenesis, lymphangiogenesis and wrinkles.
    Iriyama S; Matsunaga Y; Amano S
    Exp Dermatol; 2010 Nov; 19(11):965-72. PubMed ID: 20100191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer.
    Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P
    Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.